Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition

Ann Intern Med. 2018 Dec 4;169(11):819-820. doi: 10.7326/L18-0315. Epub 2018 Jul 31.

Authors

Giacomo De Luca¹, Corrado Campochiaro¹, Charles A Dinarello², Lorenzo Dagna¹, Giulio Cavalli¹

Affiliations

¹ Vita-Salute San Raffaele University and Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy (G.D., C.C., L.D., G.C.).
² University of Colorado Denver, Aurora, Colorado (C.A.D.).

PMID: 30073251
DOI: 10.7326/L18-0315

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Cardiomyopathy, Dilated / diagnosis
Cardiomyopathy, Dilated / drug therapy*
Cardiomyopathy, Dilated / pathology
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
Male
Middle Aged
Treatment Outcome

Substances

Interleukin 1 Receptor Antagonist Protein